Advertisement

Daktari Diagnostics Inc., a Cambridge biotech developing blood-based diagnostic tools for the developing world, has reported a $1.25 million debt funding, according to a filing with the U.S. Securities and Exchange Commission.

Daktari, founded in 2008, reported that it has sold $1,178,530 so far in the offering. The company had raised at least $5 million in total during three previous equity rounds, most recently in 2010.     

SOURCE

Advertisement
Advertisement